Erste Asset Management GmbH »

Immunitybio shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2024-12-31 $425k 153k 2.78
2024-09-30 $601k 153k 3.93
2024-06-30 $1.0M 153k 6.54
2024-03-31 $835k 153k 5.46
2023-12-31 $797k 153k 5.21

More positions owned by Erste Asset Management GmbH

Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Progressive Corp Common Stock (PGR)
Unitedhealth Group Common Stock (UNH)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Netflix Common Stock (NFLX)
Adobe Common Stock (ADBE)
Costco Whsl Corp Common Stock (COST)
Lam Research Corp Common Stock (LRCX)
Servicenow Common Stock (NOW)
Sarepta Therapeutics Common Stock (SRPT)
Applied Matls Common Stock (AMAT)

View all positions for Erste Asset Management GmbH

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Morgan Stanley
Geode Capital Management
Woodline Partners
Cormorant Asset Management
Tang Capital Management
UBS Group
Susquehanna International
Northern Trust
Charles Schwab Investment Management
Perceptive Advisors
Goldman Sachs Group
Jpmorgan Chase & Co

View all funds holding Immunitybio